Bioventus Inc. (NASDAQ:BVS) Q4 2024 Earnings Call Transcript
Operator: Good morning and welcome to the Bioventus Fourth Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode.
Bioventus Inc. (BVS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Juniper Investment Company Alexis Michas And John Bartholdson | 6,939,357 | $72,863,248 | 28.7% | |
| 2. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 4,026,809 | $42,281,494 | -8% | 1.81% |
| 3. | Driehaus Capital Richard Driehaus | 1,119,855 | $11,758,478 | +34% | 0.09% |
| 4. | Royce & Associates Chuck Royce | 732,236 | $7,688,478 | +5% | 0.07% |
| 5. | Ophir Asset Management Steven Ng And Andrew Mitchell | 424,708 | $4,459,434 | -19% | 0.66% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.55 | 25,500 | Large Shareholder, Director | 6,939,357 | 2024-08-19 | Filing | |
| $8.55 | 80,000 | Large Shareholder, Director | 6,913,857 | 2024-08-16 | Filing | |
| $4.14 | 26,595 | Officer, Director | 26,595 | 2023-08-18 | Filing | |
| $4.14 | 13,290 | Officer, Director | 138,290 | 2023-08-18 | Filing | |
| $4.79 | 14,985 | Large Shareholder, Director | 6,833,857 | 2023-08-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.57 | 3,875 | Officer | 141,088 | 2025-04-11 | Filing | |
| $7.57 | 2,958 | Officer | 131,416 | 2025-04-11 | Filing | |
| $7.57 | 1,283 | Officer | 55,557 | 2025-04-11 | Filing | |
| $9.79 | 5,479 | Officer | 131,963 | 2025-03-24 | Filing | |
| $9.75 | 1,018 | Officer | 52,540 | 2025-03-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 53,960 | $493,726 | 0% | |
| 2. | 36,829 | $336,985 | 0% | |
| 3. | 19,655 | $179,844 | 0% | |
| 4. | 1,500 | $13,725 | 0.01% | |
| 5. | 682 | $6,240 | 0% |
News See All
Bioventus Inc. (NASDAQ:BVS) Q3 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Bioventus Third Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode.
Bioventus Inc. (NASDAQ:BVS) Q2 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Bioventus Second Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions].
Bioventus Inc. (NASDAQ:BVS) Q1 2024 Earnings Call Transcript
Bioventus Inc. beats earnings expectations. Reported EPS is $0.07, expectations were $-0.05. Bioventus Inc.
Bioventus Inc. (NASDAQ:BVS) Q4 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Bioventus Inc. Fourth Quarter 2023 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
Bioventus Inc. (NASDAQ:BVS) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. My name is Dustin, and I will be your conference operator today. This time, I would like to welcome everyone to Bioventus Inc.
Bioventus Inc. (NASDAQ:BVS) Q2 2023 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to Bioventus, Inc. Second Quarter 2023 Earnings Conference Call. I will now turn the call over to your host for today, Mr.
Hedge Fund and Insider Trading News: Cathie Wood, Chase Coleman, Lansdowne Partners, Miller Value Partners, Metacapital Management, Picton Mahoney Asset Management, Nordea Asset Management, Boston Properties, Inc. (BXP), Barnwell Industries, Inc. (BRN), and More
London-based investment manager Lansdowne Partners LLP said on Wednesday it had agreed to acquire the $1.1 billion UK equities manager CRUX Asset Management, subject to regulatory approval, according ...
Bioventus Inc. (NASDAQ:BVS) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Bioventus Inc. First Quarter 2023 Earnings Conference Call.
Bioventus Inc. (NASDAQ:BVS) Q4 2022 Earnings Call Transcript
Operator: Good day. And welcome to the Bioventus Incorporated Fourth Quarter 2022 Earnings Conference Call. All participants will be in a listen-only mode.
Billionaire Hedge Funds
